Members of the genus *Flavivirus* within the family *Flaviviridae* comprise of several medically important pathogens including the Japanese encephalitis virus (JEV), dengue virus (DENV), yellow fever virus (YFV) and West Nile virus (WNV) which cause significant morbidity and mortality in humans, animals and birds[@b1]. Flaviviruses are enveloped viruses with a positive-sense, single-strand RNA genome of approximately 11 kb that is translated as a single polyprotein precursor of \~3300 amino acids in length and proteolytically cleaved into 10 viral proteins: three structural (capsid, pre-membrane/membrane (prM-M), and envelope) and seven non-structural (NS1, NS2A, NS2B, NS3, NS4A, NS4B, and NS5) proteins[@b1]. Flaviviruses enter their host cells through a process of receptor-mediated endocytosis followed by subsequent fusion within the endosomal compartment to release the viral genome into the cytoplasm for translation and replication[@b2]. Replication of the viral RNA genome occurs on virus-induced host cell membranes. Such structures may serve as a scaffold for anchoring the viral replication complexes, which consist of viral RNA, viral proteins, and host cell factors. Virus assembly occurs within the endoplasmic reticulum-derived membrane compartments and non-infectious virions traverse through the Golgi stack to reach the trans-Golgi network (TGN) where furin-mediated cleavage between prM-M leads to conformational changes rendering the virion infectious. Infectious virus is subsequently released from cells via the secretory pathway[@b1][@b3].

Adaptor complexes (AP-1 through 5) are heterotetrameric protein complexes comprising one each of the two large sub-units γ, α, δ, ε and ζ and β1-5 and one medium sub-unit μ1-5 and one small sub-unit σ1-5 respectively. APs are involved in distinct intracellular vesicular transport pathways which play a vital role in maintaining cellular homeostasis[@b4][@b5][@b6]. AP-1 is involved in the trafficking of cargo molecules in the biosynthetic pathway from the trans-Golgi network (TGN) to endosomes and back. AP-2 which is one of the most extensively-studied adaptor complex has been shown to be involved in the endocytic pathway at the plasma membrane. AP-3 is reported to function in the transport of selected proteins in the endo-lysosomal pathway. AP-4 is involved in sorting of proteins destined to basolateral surface in polarized cells. AP-5 is the newest member of the family discovered recently and has been proposed to function at the late endosomes[@b6]. Despite the prominent role played by APs in intracellular trafficking pathways, their involvement in flavivirus life-cycle has not been characterized. A number of earlier studies investigating the internalization of flaviviruses have shown the involvement of clathrin-dependent and lipid raft-dependent pathways for virus entry but the role of APs in stages post-entry has not been investigated[@b2]. A genome-wide RNA interference screen for identifying cellular proteins associated with WNV infection identified AP-1 μ1 subunit and AP-3 σ2 subunit as some of the host factors required for both WNV and DENV infection[@b7]. Similarly, another study identified *AP1M1* as one of the genes required for secretion of recombinant subviral particles of dengue virus 1 by using a siRNA screen of 122 genes involved in membrane trafficking[@b8]. However the exact role of AP-1 and AP-3 in flavivirus life cycle is poorly understood and it is not clear if AP-1 and AP-3 play redundant functional roles or are involved in distinct pathways crucial for virus infection. In this study, we have utilized cells lacking functional AP-1 or AP-3 and tested for the effect of this deficiency in DENV, JEV and WNV replication. We show that AP-3 plays an important role at earlier stages of viral life cycle whereas AP-1 is required at later stages suggesting that the flaviviruses differentially utilize the cellular trafficking pathways involving AP-1 and 3 at post-entry stages.

Results
=======

AP-1-deficiency affects later stages of DENV and WNV infection
--------------------------------------------------------------

In order to understand the role of AP-1 in mosquito-borne flavivirus life-cycle, we infected MEFs derived from wild-type and μ1A-deficient (AP-1-deficient) mice with DENV or WNV or JEV and viral titers in the supernatants were measured at the indicated time points post-infection (pi) by plaque assays. Both DENV and WNV titers were significantly less at 24 h pi and the effect was much more prominent at 48 h pi possibly suggesting that AP-1 deficiency affects later stages of virus infection. Surprisingly, JEV titers were unaffected at both 24 and 48 h pi ([Fig. 1a--c](#f1){ref-type="fig"}). AP-1 is localized at the TGN and endosomes and mediates protein sorting at these compartments[@b9]. Lack of AP-1 could specifically affect post-maturation events in DENV and WNV life-cycle and may lead to aberrant secretion of infectious virus. To test this, we infected wild type and AP-1-deficient MEFs with DENV and measured intracellular virus titers at 24 and 48 h pi. As expected, we observed enhanced intracellular viral titers in AP-1-deficient cells ([Fig. 2a](#f2){ref-type="fig"}) at 48 h pi. This was also confirmed by qRT-PCR for dengue viral RNA levels in these cells which showed a significant increase in the amount of viral RNA at 48 hpi ([Fig. 2b](#f2){ref-type="fig"}). These data confirm accumulation of infectious virions in these cells suggesting a defect in viral egress. We next tested if DENV infection affects the localization of AP-1 in Huh-7 cells. We observed partial colocalization of DENV with AP-1 and also with the TGN-resident protein TGN 46 in the perinuclear region at 24 h pi and DENV infection did not affect the localization of AP-1 as confirmed by unaltered colocalization of AP-1 with TGN46 ([Fig. 3](#f3){ref-type="fig"} and [Figure S2a, S2b and S2c](#s1){ref-type="supplementary-material"}). Further, no colocalization was observed with the late endosome/lysosome marker LAMP-1 whereas we observed a positive correlation in the colocalization of capsid and AP-1 at the TGN ([Figure S2b and S2c](#s1){ref-type="supplementary-material"}). These observations suggests that AP-1-mediated trafficking may be involved in the egress of some of the flaviviruses.

Effect of AP-3-deficiency on flavivirus life-cycle
--------------------------------------------------

Both AP-1 and AP-3 are involved in protein sorting at the TGN and endosomes. To further understand if AP-1 and AP-3 play distinct or redundant roles in flavivirus infection, we infected MEFs derived from wild-type and AP-3-deficient (*mocha*) mice with DENV or WNV or JEV and viral titers in the supernatants were measured at the indicated time points by plaque assays. In AP-3-deficient MEFs, both JEV and DENV growth was severely impaired and the viral titers were 100-1000-fold lower compared to wild-type MEFs at 48 h pi ([Fig. 4 a and c](#f4){ref-type="fig"}). In case of WNV, replication continued to progress even at 48 hpi, albeit at close to 100-fold lower levels in AP-3-deficient cells compared to wild-type cells ([Fig. 4b](#f4){ref-type="fig"}). These results indicate that flaviviruses have differential requirement for AP-1 and AP-3. While AP-1 most likely participates at later stages of infection of DENV and WNV, AP-3 seems to play a major role in the replication of all the three flaviviruses tested. To assess if lack of AP-3 results in blockade of viral assembly and maturation or earlier stages of infection, we estimated the amount of intracellular virus titers upon JEV infection and observed a hundred-fold reduction in viral titers in AP-3-deficient cells (data not shown). We next prepared cell lysates from JEV-infected cells and performed western blot analysis for JEV-capsid protein. We found that while JEV-C levels in wild-type cells could be detected at 24 h pi which rapidly increased at 48 h pi, the same was below the level of detection in AP-3-deficient cells even at 48 h pi indicating a block prior to viral poly-protein translation ([Fig. 4d](#f4){ref-type="fig"}).

Our results suggest that the lack of AP-3 affects JEV life-cycle at a stage prior to viral protein translation presumably at the level of viral entry, capsid disassembly or viral RNA replication. We next quantitated JEV and DENV genome copy numbers from infected wild-type and AP-3-deficient cells by qRT-PCR. Viral RNA levels were similar at 1 h pi, which indicates RNA from input virus, suggesting that there was no defect in viral entry. JEV RNA levels started to increase between 1 to 8 h pi and viral replication continued to increase till 48 h pi in wild-type cells. In contrast, in cells lacking AP-3, viral RNA replication did not begin until about 8 h pi and even at 48 h pi JEV RNA levels remained 100-fold lower in these cells compared to wild-type cells ([Fig. 5a](#f5){ref-type="fig"}). The effect seemed much more drastic in DENV infection as viral replication remained at background levels even at 48 h pi ([Fig. 5a](#f5){ref-type="fig"}). We performed indirect immunofluorescence analysis in wild-type and AP-3-deficient cells infected with JEV to visualize dsRNA to monitor the kinetics of viral RNA replication. We observed foci of dsRNA in wild-type cells as early as 4 h pi which increased by 8 h pi suggesting active replication of viral RNA. In AP-3-deficient cells very few punctate dsRNA structures were visible even at 8 h pi further demonstrating a delay in initiation of RNA replication in these cells ([Fig. 5b](#f5){ref-type="fig"}). These results indicate that AP-3 is involved at earlier stages of JEV and DENV life-cycle possibly at the level of viral RNA replication. Flavivirus RNA replication is reported to be semi-conservative wherein plus-strand RNA accumulates in excess in comparison to the minus-strand. Therefore, we investigated if AP-3-deficient cells have altered positive to negative strand ratio by performing strand-specific cDNA synthesis and quantitation of positive and negative strand RNA amounts by real-time PCR. Both wild-type and AP-3-deficient cells infected with JEV had approximately 20:1 ratio of positive to negative strand suggesting that the RNA synthesis *per se* is not affected ([Fig. 6a](#f6){ref-type="fig"}). This indicates that the observed defect is due to non-availability of factors required for viral RNA replication or due to a delay/defects in steps prior to RNA replication namely viral-endosomal membrane fusion or capsid disassembly. To assess if the reduced amount of viral genome observed in AP-3-deficient cells was due to defective viral entry, we transfected wild type and AP-3-deficient cells with total RNA isolated from JEV-infected cells. This would circumvent the receptor-mediated entry event and enable direct initiation of viral RNA replication in the cytosol. We isolated RNA from transfected cells for estimation of viral genome copy numbers at 48 h post-transfection and also estimated viral titers from the supernatants. We observed a 90% reduction in JEV genome equivalents and undetectable virus in the culture supernatants in AP-3-deficient cells as compared to wild type cells ([Fig. 6b & 6c](#f6){ref-type="fig"}). Similar results were obtained from RNA isolated from purified culture supernatants from infected cells (data not shown). Quantitation of input viral RNA from transfected cells at early time points did not show any difference between wild type and AP-3-deficient cells suggesting that the observed defects at late stages is not due to differences in the transfection efficiencies ([Fig. S1](#s1){ref-type="supplementary-material"}). These results clearly demonstrate that the defective viral RNA replication observed in AP-3-deficient cells is not due to disruption of viral entry or endosomal fusion processes in these cells. Therefore, it is plausible that some of the cargo proteins sorted by AP-3 at the endosomes are involved in DENV and JEV RNA replication and therefore, these viruses usurp AP-3-mediated trafficking pathway to facilitate viral RNA replication. To test if AP-3 is associated with sites of viral RNA replication, we infected Huh-7 cells with DENV and at 16 h pi, cells were stained for dsRNA and δ-adaptin. As shown, AP-3 was found to colocalize with most of the dsRNA punctate structures suggesting the recruitment of AP-3 to viral replication compartments ([Fig. 7](#f7){ref-type="fig"} and [Fig. S5](#s1){ref-type="supplementary-material"}). Similar results were obtained with wild-type MEFs infected with JEV where most of the dsRNA colocalized with δ-adaptin ([Fig. S3a and S3b](#s1){ref-type="supplementary-material"}). These results suggest that AP-3 deficiency could be affecting viral RNA replication either by a direct involvement in viral RNA replication or by transporting factors essential for viral RNA replication to the compartments where viral replication occurs.

Discussion
==========

The importance of AP-1 in the biosynthetic and the endo-lysosomal pathways has been demonstrated by animals carrying mutations/deletions. AP-1 is required for anterograde TGN-to-early endosome as well as retrograde early-endosome-to-TGN transport[@b9][@b10][@b11]. Similarly, the role of AP-3 in the biogenesis of lysosomes and lysosome-related organelles such as melanosomes is clearly demonstrated by the phenotype of mice and humans carrying mutations/deletions in various subunits of the AP-3 complex[@b9][@b12]. The *mocha* mouse (from which the MEFs used in this study was derived) carries a deletion in the *Ap3d1* gene which encodes the δ1 subunit of the AP-3 complex. The other three sub-units of the AP-3 complex are barely detectable in *mocha* mice suggesting that the δ1 subunit is essential for maintaining the stability of this heterotetrameric protein complex[@b13]. In the present study, we show that the heterotetrameric adaptor complexes AP-1 and AP-3 are involved at different stages of infection of RNA viruses belonging to *Flaviviridae* family. AP-1 was required at later stages of DENV and WNV life-cycle as observed by reduction in the extracellular virus titers and partial colocalization of DENV with AP-1 in the perinuclear area. AP-3 was essential for the initiation of RNA replication of JEV, DENV and WNV. Based on our results we propose a model where AP-3 is involved at a stage post-entry at the stage of viral genome replication ([Fig. 8a](#f8){ref-type="fig"}). AP-1 seems to play a role at later stages of DENV and WNV life-cycle probably post-maturation of the virion or viral egress at the TGN where most of the AP-1 is normally localized ([Fig. 8b](#f8){ref-type="fig"}). This is supported by our data showing increased intracellular DENV in AP-1-deficient cells suggesting a role for AP-1 in transport of infectious virus at later stages of viral life-cycle. Our unpublished results and recent reports suggest that JEV infection does not depend on clathrin coats. Our observation that lack of AP-1, which associates with clathrin-coated vesicles, does not affect JEV infection is in line with these observations. Further studies are required to identify if JEV exits host cells using an alternate pathway which is independent of AP-1 and clathrin-coated vesicles[@b14].

AP-3 δ-subunit has been shown to interact with the matrix region of HIV-1 Gag and this interaction was shown to be necessary for Gag trafficking to multi-vesicular bodies and HIV particle formation[@b15][@b16][@b17]. Understanding the exact functional role of AP-3 in flaviviral life-cycle warrants further investigation. AP-3 may directly be involved in viral replication by binding to one of the viral proteins or indirectly by delivering cargos that are essential for viral RNA replication at the virus-induced replication compartments. We have observed that a number of flaviviral proteins contain the consensus sequence YxxØ and \[D/E\]xxxL\[L/I\] to which μ, β and σ sub-units of APs have been shown to bind on other cargo proteins[@b18]. Thus it remains to be ascertained if any of these viral proteins are capable of binding μ3 or β sub-units. Our study suggests that AP-3-mediated pathways involved in the biogenesis of endosomes/lysosomes play a crucial role in flavivirus RNA replication. Since many earlier reports have shown that flavivirus particles enter the cells reaching early endosomes and subsequently late endosome/lysosome[@b19][@b20][@b21], it is plausible that AP-3-mediated trafficking in the endo-lysosomal system may be required for initiation of viral replication after release of the viral genome post capsid disassembly. Our infectious RNA transfection data suggests that AP-3 acts at the level of initiation of RNA replication. Some of the potential cargos of AP-3 that may play a role in RNA virus replication could be phosphatidylinositol 4-kinase type II alpha (PI4KIIalpha) and intermediate filament complex[@b22][@b23]. Recruitment of AP-1 onto membranes at the TGN has been reported to be dependent on phosphatidylinositol 4-phosphate (PI4P)[@b24]. Similarly, PI4KIIalpha activity has been shown to be necessary for recuitment of AP-3 onto membranes enriched in PI4P[@b25]. Some of the earlier studies have identified an important role for other PI4Ks in picornavirus replication and also in heptitis C virus infection[@b26]. If PI4KIIalpha plays a similar role in flavivirus life cycle warrants further investigation. Therefore, our future efforts would focus on exploring some of these aspects and characterize the exact role played by AP-3 in viral replication of some of the RNA viruses. In summary, our study has identified AP-1 and AP-3 as crucial components of flavivirus life-cycle and we believe that our observations will help us to further understand the role of APs in the pathogenesis of these globally important pathogens.

Methods
=======

Cell lines and viruses
----------------------

All cell lines and their growth conditions have been described before[@b10][@b27]. Porcine kidney (PS) cells, Vero and BHK-21 cells were grown in the minimal essential medium (MEM) containing 10% FBS, Earl\'s salts and antibiotics. JEV and WNV strain has been described before[@b27]. DENV-2 (P23085 INDI-60) were obtained from the National Institute of Virology, Pune, India and propagated in C6/36 insect cells in the above medium at 28°C. Infected culture supernatant was used throughout the study. Viral titers were determined by plaque assay on PS cells for JEV, Vero cells for WNV and BHK-21 cells for DENV as described previously[@b27][@b28].

Virus growth experiments
------------------------

MEFs were seeded in 24-well plate (10^5^ cells/well) and infected with 0.3 MOI of JEV, 0.3 or 0.1 MOI of WNV and 1 MOI of DENV-2. Virus containing medium (DMEM supplemented with 2% FBS along with other additives as above) was added to the cells and incubated at 37°C on rocker for 1 hour. Virus inoculum was removed and cells were washed twice with PBS and re-fed with normal growth medium. Culture supernatants were collected at the indicated times post-infection and viral titers were determined by plaque assays. After collection of supernatants at above indicated time points, cells were washed once with PBS, trypsinised and resuspended in complete medium. Cells were then centrifuged at 500 × g for 5 min at 4°C. Medium was discarded and cell pellet was resuspended in 250 μl Trizol (for isolation of total RNA for quantitative real-time PCR) or in 100 μl PBS (for intracellular viral titers). For intracellular viral titers, cells were resuspended in PBS and subjected to three rounds of freeze-thaw cycles by dipping the tubes sequentially in liquid nitrogen and 37° C water bath. Cell lysates were centrifuged at 12000 × g for 10 minutes and intracellular viral titers in the lysed supernatants were determined by plaque assay.

Quantitative real-time PCR
--------------------------

Total cellular RNA was isolated using Trizol reagent. To remove genomic DNA contaminants, 1 μg of total RNA was treated with 1.0 unit of RNAse free DNAse I for 30 minutes at 37°C and then 10 minutes at 65°C to inactivate the DNAse. 100 ng of total RNA was used to determine genome copy numbers using one-step quantitative RT-PCR using primers and probe described previously[@b28][@b29][@b30]. Each sample was tested in duplicates and viral genome copy numbers in the samples were calculated from a standard curve generated using pre-quantified *in vitro* transcribed specific RNA standards. Genome copy numbers were normalized to GAPDH mRNA levels (glyceraldehyde-3-phosphate dehydrogenase) \[primers: Fwd: 5′-TGTGTCCGTCGTGGATCTGA-3′, Rev: 5′-CCTGCTTCACCACCTTCTTGA-3′, probe: 5′-FAM-CCGCCTGGAGAAACCTGCCAAGTATG-TAMRA\] determined in parallel. Relative expression was calculated using comparative threshold cycle method and viral titers were expressed as genome equivalents/μg RNA. For detection of positive or negative strand JEV RNA, cDNA synthesis was performed using SuperScript III First-Strand Synthesis System (Invitrogen) with either forward or reverse primers used in qRT-PCR. Fold change in expression of positive and negative strand RNA was quantified by qRT-PCR as desribed above.

Western blot
------------

MEFs were infected with JEV with an MOI of 1 pfu/cell and at 24 and 48 h pi, cells were washed with ice-cold PBS and lysed in RIPA buffer (50 mM Tris-Cl pH-8.0, 150 mM NaCl, 1% IGEPAL CA-630, 0.5% sodium deoxycholate, 0.1% SDS, 1× protease inhibitor cocktail). Lysates were incubated on ice for 10 min and centrifuged at 12,000 × g for 10 min at 4°C. Supernatants were collected and boiled in 4× Laemmli buffer and resolved on SDS-PAGE and transferred onto membranes, incubated with primary antibodies (mouse anti-β-actin (Sigma-Aldrich), rabbit polyclonal anti-JEV capsid raised in-house) at 4°C overnight followed by three washes with TBST and one hour incubation with HRP-conjugated secondary antibodies. Blots were washed three times with TBST and once with TBS and developed by enhanced chemiluminescence substrate.

Immunofluorescence
------------------

Cells grown on coverslips were infected with JEV or DENV with indicated MOIs. At indicated time points, cells were washed twice in PBS containing 1.0 mM Ca^2+^ and 0.5 mM Mg^2+^ and then fixed in 3% paraformaldehyde for 20 min. Samples were quenched with PBS containing 0.1 M glycine and then washed twice with PBS. Cell membranes were permeabilized with PBS containing 0.1% Triton X-100 for 5 min and then non-specific antibody binding sites were blocked by incubating with PBS containing 2% normal goat serum for 10 min at room temperature (RT). Fixed cells were washed three times with PBS-Triton buffer, followed by incubation with one or more of the following antibodies: anti-TGN46 (AbD Serotec), anti dsRNA antibody J2 (English & Scientific Consulting Bt., Hungary), anti-delta adaptin antibody (SA-4) and LAMP-1 antibody (H4A3) (Developmental Studies Hybridoma Bank from the University of Iowa) or mouse anti-human delta adaptin antibody (BD Biosciences), anti-gamma adaptin antibody (BD Biosciences) and anti-DENV-capsid polyclonal antibody generated in-house against a purified recombinant dengue capsid protein. Cells were incubated with primary antibodies for 1 h at RT, washed three times with PBS-Triton buffer and incubated with secondary antibodies conjugated with Alexa-flour dyes for 1 h at RT. Coverslips were mounted onto microscope slides using ProLong Gold Antifade containing DAPI and left overnight at RT. Images were acquired using 20× or 100× objective in Olympus FLUOVIEW FV1000 confocal microscope.

Viral RNA transfection
----------------------

Wild type MEFs were infected with JEV at an MOI of 0.3 pfu/cell and 48 h pi RNA was isolated from infected cells and used for transfecting wild type and AP-3 deficient MEFs in a 24-well plate (7.5 × 10^4^ cells/well) using Lipofectamine 2000. Transfection media was replaced with complete media with antibiotics after about 14 hours post-transfection. Supernatants were collected at 48 h post-transfection for plaque assay and cells were collected in Trizol for detection of viral RNA by qRT-PCR using one-step PCR Taqman reagents. For determination of transfection efficiency, the amount of input RNA was measured at 8 h post-transfection by preparing total RNA and estimating the copy numbers by qRT-PCR as described above.

Statistical analysis
--------------------

GraphPad Prism software was used for all graphical representations and statistical analysis. All experiments were performed in two or three replicates samples and each figure is representative of experiments performed at least three times. P values were estimated by non-parametric, unpaired, two-tailed t-test.
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![Flavivirus production in AP-1-deficient cells.\
Wild type (WT) and AP-1-deficient (μ1A-/-) MEFs were infected with 1 MOI of DENV-2 (**a**) or 0.3 MOI of WNV (**b**) or JEV (**c**) and viral titers in culture supernatants were determined at indicated time points by plaque assay. Error bars represent Mean ± SEM. Data are representative of three experiments performed with three replicates each. P values were calculated by non-parametric, two-tailed, t-test. The difference was insignificant in JEV infected cells.](srep01813-f1){#f1}

![AP-1 is required at later stages of DENV life-cycle.\
**(a)** MEFs were infected with DENV (MOI of 1pfu/cell) and at indicated time points cells were collected and intracellular viral titers were determined by plaque assay as described above. **(b)** Cells were infected with DENV (1 MOI) and at indicated time points infected cells were harvested for RNA isolation and dengue genome copy number determination by qRT-PCR. Error bars represent Mean ± SEM. Data are representative of two experiments performed with three replicates. P values were calculated by non-parametric, two-tailed, t-test.](srep01813-f2){#f2}

![DENV partially colocalizes with AP-1.\
Huh-7 cells were infected with DENV (3 MOI) and 24 h pi, cells were fixed and stained with antibodies against γ-adaptin and DENV-capsid followed by secondary antibodies conjugated with Alexa 488 and Alexa 568 respectively. Nuclei was stained with DAPI. Overlap image with a small region of interest showing colocalization is shown in the inset.](srep01813-f3){#f3}

![Effect of AP-3 deficiency on flavivirus infection.\
Wild type (WT) and AP-3-deficient (*mocha*) MEFs were infected with an MOI of 1 pfu/cell of DENV-2 (**a**) or 0.1 pfu/cell of WNV (**b**) or 0.3 pfu/cell of JEV (**c**) and viral titers in culture supernatants were determined at indicated time points by plaque assay. Error bars represent Mean ± SEM. Data are representative of three experiments performed with two or more replicates. (**d**) MEFs were infected with JEV and at indicated time points post-infection cell lysates were prepared and subjected to western blots and probed with JEV-capsid and β-actin antibodies.](srep01813-f4){#f4}

![Defective viral RNA replication in AP-3-deficient cells.\
**(a)** Cells were infected with JEV (0.3 MOI) or DENV (1 MOI) and at indicated time points infected cells were harvested for RNA isolation and copy number determination by qRT-PCR. Error bars represent Mean ± SEM. Error bars in some points are not visible on logarithmic scale. Data are representative of two or more experiments performed with three replicates. **(b)** Cells were grown on coverslips and infected with JEV (MOI of 10 pfu/cell). At indicated time points cells were fixed with PFA and stained with anti-dsRNA antibody followed by Alexa-488 conjugated secondary antibody. The nuclei were stained by DAPI. Scale bar -- 10 μm.](srep01813-f5){#f5}

![AP-3 is required for viral RNA replication.\
**(a)** Cells were infected with JEV (3 MOI) and 24 h pi cells were harvested for RNA isolation. Positive and negative strand viral RNA was quantitated by qRT-PCR as described in methods. GAPDH was used for normalization. Error bars represent Mean ± SEM. Data are representative of two experiments performed with three replicates. **(b--c)** Wild type or AP-3-deficient *mocha* cells were transfected with RNA from JEV-infected cells and 48 h pi JEV RNA levels were estimated by real time PCR from RNA-transfected cells and viral titers from the supernatant was determined by plaque assay. Error bars represent Mean ± SEM. N.D. -- Not detected.](srep01813-f6){#f6}

![AP-3 colocalizes with viral RNA.\
Huh-7 cells were grown on coverslips and were infected with DENV (MOI of 5 pfu/cell). At 16 h pi cells were fixed and stained with antibodies against dsRNA and δ-adaptin followed by Alexa-546 and Alexa-488-conjugated secondary antibodies. The nuclei were stained by DAPI. Scale bar -- 10 μm. Selected region of colocalization in the overlap image is shown separately in the inset.](srep01813-f7){#f7}

![Role of AP-1 and AP-3 in flavivirus life-cycle.\
**(a)** Flaviviruses bind to attachment factors/receptors at the plasma membranes or in lipid rafts and are internalized. Virus-receptor complexes are delivered to early endosomes, which may mature into late endosomes. Fusion of viral and host membranes may occur in early or late endosomes leading to release of naked capsids which disassemble to release viral RNA into the cytoplasm for translation followed by viral RNA replication via negative strand intermediates. The possible step at which AP-3 may be involved is indicated. **(b)** Immature virions traverse through the Golgi stack and enter the TGN where furin-mediated cleavage between prM-M renders the virion infectious due to conformational changes. Infectious virions exit the TGN and are secreted out of the cells presumably by the constitutive secretory pathway. AP-1 is possibly involved at the egress stage from the TGN.](srep01813-f8){#f8}
